Results 131 to 140 of about 19,024 (248)
Ritlecitinib induced rapid clinical improvement in moderate‐to‐severe alopecia areata in real‐world practice. Early change in SALT at Week 12 strongly discriminated Week‐24 responders, supporting a pragmatic treat‐to‐target checkpoint, alongside improvements in clinician‐reported and patient‐reported outcomes and a favorable safety profile.
Giuseppe Gallo +4 more
wiley +1 more source
Evaluation of Point-of-Care Decision Support for Adult Acne Treatment by Primary Care Clinicians.
Li DG +5 more
europepmc +1 more source
Effects of oral supplementation with FOS and GOS prebiotics in women with adult acne: the "S.O. Sweet" study: a proof-of-concept pilot trial. [PDF]
Dall'Oglio F, Milani M, Micali G.
europepmc +1 more source
This scoping review synthesizes evidence on atopic dermatitis (AD), psoriasis, and hidradenitis suppurativa in North American Indigenous peoples across 49 studies and 63 clinical trials. Findings reveal consistently high disease burden in AD, marked underrepresentation in trials and guidelines, and five evidence‐based recommendations to advance ...
Rachel Asiniwasis +17 more
wiley +1 more source
A Review of hormone-based therapies to treat adult acne vulgaris in women. [PDF]
Trivedi MK, Shinkai K, Murase JE.
europepmc +1 more source
Development and preliminary validation of the Early Sacroiliitis Screening Tool (ESHST), a dermatology‐oriented screening questionnaire for identifying hidradenitis suppurativa patients at increased risk of spondyloarthritis. ABSTRACT Background Hidradenitis suppurativa (HS) is increasingly recognized as a systemic inflammatory disease associated with ...
Umut Bakay +3 more
wiley +1 more source
Smartphone Applications in Dermatology With Special Focus on AI: A European‐Continent‐Based Review
Our analysis of 420 dermatology mobile applications across 44 European countries revealed limited adoption of artificial intelligence and sparse scientific validation. ABSTRACT Smartphone applications for dermatology are widely available across Europe, yet evidence on their characteristics, validation, and regulatory compliance remains limited.
Tobias Sangers +23 more
wiley +1 more source
Summary of the clinical characteristics and 2‐year follow‐up of patients with HS and concomitant DS in a multicentre Italian cohort, highlighting earlier HS onset, clinical features, and improved disease severity, quality of life, and pain over follow‐up, supporting early screening and multidisciplinary care of this special population.
Chiara Moltrasio +34 more
wiley +1 more source
Diogo Pazzini Bomfim,1 Marco Alexandre Dias da Rocha,2 Adriana Sanudo,3 Edileia Bagatin2 1Translational Medicine, Federal University of Sao Paulo (UNIFESP), Sao Paulo, Brazil; 2Department of Dermatology, Federal University of Sao Paulo (UNIFESP), Sao ...
Bomfim DP, Rocha MA, Sanudo A, Bagatin E
doaj
Delphi consensus: First‐line use of biologics and small molecules in hidradenitis suppurativa
This Delphi Consensus study identified upgrade criteria for the use of biologics and small molecules as first‐line therapy in hidradenitis suppurativa (HS). European HS experts evaluated 16 clinical scenarios, voting on eligibility for therapy escalation.
Georgios Nikolakis +54 more
wiley +1 more source

